NYSE: CAH - Cardinal Health

Yield per half year: -4.96%
Sector: Healthcare

Company Analysis Cardinal Health

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Dividends (1.91%) are higher than the sector average (1.23%).
  • The stock's return over the last year (0.0107%) is higher than the sector average (-34.6%).
  • Current debt level 12.43% is below 100% and has decreased over 5 years from 22.55%.
  • The company's current efficiency (ROE=-28.1%) is higher than the sector average (ROE=-80.97%)

Disadvantages

  • Price (93.8 $) is higher than fair price (44.38 $)

Similar companies

Humana

UnitedHealth Group

Bristol-Myers

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Cardinal Health Healthcare Index
7 days -18.8% -0.1% 1.6%
90 days -12.9% -42% 6.4%
1 year 0% -34.6% 31.2%

CAH vs Sector: Cardinal Health has outperformed the "Healthcare" sector by 34.61% over the past year.

CAH vs Market: Cardinal Health has significantly underperformed the market by -31.22% over the past year.

Stable price: CAH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: CAH with weekly volatility of 0.000205% over the past year.

3. Summary of the report

3.1. General

P/E: 30.41
P/S: 0.1142

3.2. Revenue

EPS 3.45
ROE -28.1%
ROA 1.92%
ROIC 41.08%
Ebitda margin 1.26%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (93.8 $) is higher than the fair price (44.38 $).

Price is higher than fair: The current price (93.8 $) is 52.7% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (30.41) is lower than that of the sector as a whole (57.99).

P/E vs Market: The company's P/E (30.41) is lower than that of the market as a whole (47.35).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (-8.07) is lower than that of the sector as a whole (9.41).

P/BV vs Market: The company's P/BV (-8.07) is lower than that of the market as a whole (22.57).

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.1142) is lower than that of the sector as a whole (4.07).

P/S vs Market: The company's P/S indicator (0.1142) is lower than that of the market as a whole (15.08).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (9.22) is lower than that of the sector as a whole (17.46).

EV/Ebitda vs Market: The company's EV/Ebitda (9.22) is lower than that of the market as a whole (22.75).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -7.47% over the last 5 years.

Accelerating profitability: The return for the last year (226.44%) exceeds the average return for 5 years (-7.47%).

Profitability vs Sector: The return for the last year (226.44%) exceeds the return for the sector (-14.25%).

5.4. ROE

ROE vs Sector: The company's ROE (-28.1%) is higher than that of the sector as a whole (-80.97%).

ROE vs Market: The company's ROE (-28.1%) is lower than that of the market as a whole (16.86%).

5.5. ROA

ROA vs Sector: The company's ROA (1.92%) is lower than that of the sector as a whole (6.65%).

ROA vs Market: The company's ROA (1.92%) is lower than that of the market as a whole (6.56%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (41.08%) is higher than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (41.08%) is higher than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (12.43%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 22.55% to 12.43%.

Excess of debt: The debt is not covered by net income, percentage 658.33%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 1.91% is higher than the average for the sector '1.23%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 1.91% has been steadily paid over the past 7 years, DSI=0.93.

Weak dividend growth: The company's dividend yield 1.91% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (58.57%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
07.08.2023 Mayer Jessica L
Chief Legal/Compliance Officer
Purchase 51.49 41 861 813
18.01.2023 Snow Ola M
Chief Human Resources Officer
Purchase 53.12 5 949 112

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Cardinal Health

9.3. Comments